51 results
Page 2 of 3
20-F/A
8lp83q
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
y7zofkgd9ffu4
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
h1apppncgwvra5n1ki
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
kvzmyao0
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99.1
wdgf kgm6c7r8vrxv
14 Jan 15
BioLineRx Announces Completion of Enrollment in CE
12:00am
6-K
EX-99
neur gcvrpcqz
31 Oct 14
BioLineRx Reports Publication in Peer Review Journal of
12:00am
6-K
EX-99
rvkob 66tguhz9sueej
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
dwj472e
7 Oct 13
BioLineRx Announces Receipt of Notice of Allowance
12:00am
424B3
pmms18r9ph5u78nlvdbl
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
u79bt d6iv
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
6-K
EX-99
3mop3ff
30 Apr 13
Current report (foreign)
12:00am
424B3
h2j4fgg
15 Oct 12
Prospectus supplement
12:00am
F-1
6w5v 8taoxqbw56xhp
2 Oct 12
Registration statement (foreign)
12:00am
S-8
EX-3.1
vwwdt9 h9pfjtp6b9me
19 Sep 12
Registration of securities for employees
12:00am
6-K
EX-99
66ijgw w3
5 Jun 12
BioLineRx Announces Receipt of Two Notices of
12:00am
6-K
EX-99
3fle vpra
25 Apr 12
BioLineRx Announces Extension of Patent
12:00am